Intra-Cellular Therapies (ITCI) PT Raised to $38 at BTIG
Tweet
Share
E-mailGet Alerts ITCI Hot Sheet
Price: $131.87 --0%
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
9 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
BTIG raised its price target on Intra-Cellular Therapies (NASDAQ: ITCI) to $38.00 (from $36.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- Casey's General Stores (CASY) PT Raised to $975 at Stephens
- Adobe (ADBE) PT Lowered to $379 at Bernstein SocGen Amid 'Increased Uncertainties'
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
The Children's Investment Fund (TCI), BTIGSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
